Evidence map›Paper›PMID 29145398›Full record

ArticlePLoS biology2017

Conservation demands safe gene drive.

Kevin M Esvelt, Neil J Gemmell

Abstract read
In one paragraph

Article in PLoS biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. The ethics of genome editing in non-human animals: a systematic review of reasons reported in the academic literature.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2019
    Pooled it
  2. Review
  3. Article
  4. Article
  5. Biology · 2026
    Review
  6. Article
  7. Perspectives of Gene Editing for the Conservation of Plant Genetic Resources.Methods in molecular biology (Clifton, N.J.) · 2026
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Genes drive organisms and slippery slopes.Pathogens and global health · 2024
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kevin M EsveltMIT Media Lab, Massachusetts Institute of Technology, Cambridge, Massachusetts, United States of America.
Neil J GemmellDepartment of Anatomy, University of Otago, Dunedin, New Zealand.ORCID http://orcid.org/0000-0003-0671-3637

Funding

Developing powerful daisy drive systems for the precise alteration of local populationsDP2AI136597 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ESVELT, KEVIN · 2017 to 2020
$2.5M
Sculpting the Enteric Microbiota with CRISPR-Cas SystemsR00DK102669 · NIDDK · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI ESVELT, KEVIN · 2016 to 2017
$496k
NIAID NIH HHS DP2 AI136597NIDDK NIH HHS R00 DK102669
6 · The paper itself

Abstract

Interest in developing gene drive systems to control invasive species is growing, with New Zealand reportedly considering the nascent technology as a way to locally eliminate the mammalian pests that threaten its unique flora and fauna. If gene drives successfully eradicated these invasive populations, many would rejoice, but what are the possible consequences? Here, we explore the risk of accidental spread posed by self-propagating gene drive technologies, highlight new gene drive designs that might achieve better outcomes, and explain why we need open and international discussions concerning a technology that could have global ramifications.

Indexed as

Conservation of Natural ResourcesIntroduced SpeciesAnimalsEcosystemGene Drive TechnologyGene FlowMammals

Identifiers

PMID29145398
PMCPMC5689824

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.